The NanoOmics Lab aims to advance fundamental knowledge on the interaction between nanomaterials and blood components. Our mission is to leverage the bio-nano interface to develop innovative nanoparticle-based 'liquid biopsy' platforms. Ultimately, we aim to uncover novel biomarker panels for early disease detection while unravelling the underlying biological processes.